Diploma

Sun Pharmaceutical Industries Ltd. (Sun Pharma) is the fourth largest specialty generic pharmaceutical company in the world with global revenues of over USD 5 billion. Supported by more than 40+ manufacturing facilities, SUN provides high-quality, affordable medicines, trusted by healthcare professionals and patients, to more than 100 countries across the globe.

After a journey of growth spanning 27 years as Cadila Healthcare Ltd. and the Zydus Group, we have evolved and transformed ourselves in response to the changing times. Our legacy of over 70 years in healthcare and being dedicated to life in all its dimensions is reaffirmed in our new mission, vision and purpose. Unifying ourselves under the Zydus name, Cadila Healthcare Ltd., is renamed as Zydus Lifesciences Ltd.

Intas is one of the leading multinational pharmaceutical formulation development, manufacturing and marketing companies in the world. Today, Intas is present in more than 85 countries worldwide and is growing at 20% CAGR. Around 70% of its revenues come from the international markets, particularly the highly regulated markets of EU and US. At Intas, every day and everyone works to create a world of good health, happiness and hope.

USV is a 61 year old leading healthcare company which began as a joint venture with USV&P Inc. USA, a subsidiary of Revlon. Our product offering today includes Active Pharmaceutical Ingredients (APIs), Fixed Dosages Formulations (FDF), Peptides, Biosimilars and Injectables. These are manufactured in our cGMP compliant plants located in India.

National Agri-Food Biotechnology Institute (NABI) is an autonomous Institute under the Department of Biotechnology, Government of India. NABI aims at catalyzing the transformation of the Agri-food sector in India by being a nodal organization for knowledge generation and translational science leading to value-added products based on Agri-Food biotech innovations for improved household nutritional security.

Eris Lifesciences Limited is a leading Indian branded formulations company with a strong presence in chronic and lifestyle therapies such as anti-diabetes, cardiology, nutrition and neuropsychiatry. Since its inception in 2007, Eris has demonstrated robust growth and is now ranked among the Top-20 Indian companies in the domestic branded pharmaceuticals market.

Granules India is a vertically integrated pharmaceutical company, headquartered in Hyderabad, India. We manufacture Active Pharmaceutical Ingredients APIs, Pharmaceutical Formulation Intermediates PFIs and Finished Dosages FDs, distributed to quality conscious customers in both regulated and semi-regulated markets. We are dedicated to excellence in manufacturing, quality and customer service.

MSN Group is the fastest growing research-based pharmaceutical company based out of India. Founded in 2003 with a mission to make health care affordable, this Hyderabad-based venture has nine API and five finished dosage facilities established across Hyderabad, USA and Myanmar. Innovation and speed form the crux of our business strategy.

Lupin Limited is one of India's largest manufacturers of bulk actives and formulations. The principal bulk actives manufactured by it include Rifampicin, Pyrazinamide, Ethambutol (anti-TB), Cephalosporins (anti-infectives) and cardiovasculars. The company also possesses competencies in phytomedicines, in which medicines are made out of plant and herbal resources supported by the discipline of modern medicine.

WALK-IN Interview for Experienced Candidates (2-8yrs) ONLY